Cronos Group (CRON) Stock Price, News & Analysis

Company Overview

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.

Key Stats

• Today's Range: C$2.39 to C$2.48
• 50-Day Range: C$2.50 to C$2.95
• 52-Week Range: C$2.39 to C$4.28
• Volume: 105,031 shs
• Average Volume: 265,878 shs
• Market Capitalization: C$644.32 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: C$3.54
• Consensus Rating: N/A

CRON Stock Analysis - Frequently Asked Questions

How have CRON shares performed this year?

Cronos Group's stock was trading at C$2.89 at the beginning of 2025. Since then, CRON stock has decreased by 15.6% and is now trading at C$2.44.
View the best growth stocks for 2025 here.

How do I buy shares of Cronos Group?

Shares of CRON stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Cronos Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cronos Group investors own include Aurora Cannabis (ACB), Canopy Growth (CGC), NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), NIO (NIO) and Aurora Cannabis (ACB).

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Pharmaceutical Products
• Current Symbol: TSE:CRON
• CIK: N/A
• Web: www.thecronosgroup.com
• Phone: 416-504-0004
• Fax: N/A
• Employees: 450
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: C$3.54
• High Stock Price Target: C$3.54
• Low Stock Price Target: C$3.54
• Potential Upside/Downside: +41.6%
• Consensus Rating: N/A
• Rating Score (0-4): 0.00
• Research Coverage: 0 Analysts

Profitability

• EPS (Most Recent Fiscal Year): C($0.18)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: 0.12
• Net Income: C$-32,779,583.58
• Net Margins: -42.65%
• Pretax Margin: N/A
• Return on Equity: -4.40%
• Return on Assets: -3.73%

Debt

• Debt-to-Equity Ratio: 0.17
• Current Ratio: 24.24
• Quick Ratio: 24.01

Sales & Book Value

• Annual Sales: C$76.86 million
• Price / Sales: 8.59
• Cash Flow: C$1.49 per share
• Price / Cash Flow: 1.67
• Book Value: C$2.96 per share
• Price / Book: 0.84

Miscellaneous

• Outstanding Shares: 264,064,704
• Free Float: N/A
• Market Cap: C$660.16 million
• Optionable: Not Optionable
• Beta: 1.02